Business
Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
SAN ANTONIO, May 08, 2025--A newly released white paper shares four real-world cases where bioAffinity's CyPath® Lung played a pivotal role in guiding clinical decisions.
About this update from Bioaffinity Technologies, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":201,"url":"https://media.zenfs.com/en/business-wire.com/dd0b9d2de6b5a7ced685e21227b735f1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_YpKGjXRjIJfq2hGglshyw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/dd0b9d2de6b5a7ced685e21227b735f1","width":480,"height":201}},"lazy":false},{"type":"text","content":"Dr. Gordon Downie shares case-based evidence demonstrating how CyPath® Lung improves diagnostic confidence and guides care in high-risk patients","length":144,"tagName":"p","attribs":{}},{"type":"text","content":"SAN ANTONIO, May 08, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer, today announced the release of a white paper authored by Dr. Gordon Downie, MD, PhD, Director of the Lung Nodule Clinic and Interventional Pulmonology at Titus Regional Medical Center.","length":404,"tagName":"p"},{"type":"text","content":"The paper, titled "CyPath® Lung in Practice: Cases 1-4," details real-world clinical cases in which CyPath® Lung, a noninvasive sputum-based test, significantly influenced clinical decision-making for patients with indeterminate pulmonary nodules. A majority of nodules discovered incidentally or through low dose CT screening programs are less than 20 mm. They are considered indeterminate if they cannot be definitively classified as malignant or benign based on imaging alone.","length":489,"tagName":"p"},{"type":"text","content":""Over the past year, CyPath® Lung has become an active component in our clinical assessment of newly discovered non-calcified pulmonary nodules. It has accelerated diagnosis, helped guide difficult clinical discussions, and prevented unnecessary invasive procedures," Dr. Downie said.","length":294,"tagName":"p"},{"type":"text","content":"The white paper presents four cases involving high-risk patients, including those with:","length":87,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Sub-8 mm nodules in hard-to-biopsy locations","length":44,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"...